US Healthcare
A Patient-Centric Path to National Health Sustainability
Trust is one of the biggest missing pieces in healthcare. Many Americans are hesitant to share health data because they do not want it controlled by government, insurers, or other institutions. PULZ addresses that by giving individuals control over their own health data, identity, and permissions through a neutral, commercially operated platform. That trust makes engagement more likely — and stronger engagement is what helps prevention work, improves outcomes, and reduces avoidable costs.
Value Proposition
Supporting Cost Containment Through Earlier, More Precise Engagement
Much of public healthcare spending is driven by conditions that could have been prevented or addressed earlier. PULZ helps change that by giving citizens a continuous, personalized view of their health, so they can spot risks earlier and take action before problems become crises.
By bringing real-world behavioral and lifestyle signals into the picture, PULZ helps government programs engage people earlier, identify rising risk sooner, and direct resources toward prevention instead of expensive late-stage intervention. This can support lower avoidable utilization, stronger preventive engagement, more efficient use of resources, and better alignment with value-based reimbursement goals.
PULZ improves cost efficiency through earlier engagement and better health alignment — not by restricting access or reducing benefits.
Value Proposition
Modernizing Public-Health Intelligence Without Centralized Data Control
The data used to guide public health policy is often outdated by the time it is analyzed. PULZ offers a more timely alternative: continuous, aggregated, de-identified population signals that help agencies understand what is happening now, not months later.
This can support real-time regional trend analysis, earlier detection of emerging risk clusters, live evaluation of prevention programs, and smarter resource prioritization — all within a privacy-preserving framework that does not require government access to individual health records.
No identifiable personal data is collected, stored, or made accessible to government. All insights are aggregated, de-identified, and consent-based.
.png)
Value Proposition
Privacy-First Architecture That Supports Public Trust
At PULZ we believe that the biggest obstacle to public health engagement isn't awareness — it's trust. PULZ solves it structurally. Citizens own their data. Participation is consent-driven. Government never takes custody of personal records. Benefits reach people without surveillance. When the platform protects people, people use the platform. That's how engagement scales.
Value Proposition
Anonymized Benefit Delivery and Program Support
PULZ gives governments a way to fund prevention programs, deliver benefits, and measure outcomes — without ever accessing personal data. Incentives reach citizens through the platform. Results come back as aggregated, anonymized population reporting. Public investment gets directed where impact is demonstrable — without expanding administrative burden or creating new regulatory exposure.
Value Proposition
Long-Term Economic and Workforce Impact
Sick populations are expensive twice — in healthcare and in lost economic output. PULZ invests in the upstream. Earlier engagement. Healthier behaviors. More resilient populations. The downstream return is measurable: reduced long-term program dependency, stronger workforce participation, and public finances that aren't perpetually absorbing the cost of preventable illness. Healthier people don't just cost less. They produce more.
Value Proposition
A FedRamp-High-Ready Partner, Not a Government System
PULZ is not a government system — and that's precisely what makes it valuable to government. Independent. Commercially operated. Citizen-owned. And built on a FedRAMP High-certified records and engagement core that meets federal security standards without requiring agencies to build, certify, or operate anything themselves. A partner that delivers population health outcomes without administrative burden, regulatory exposure, or the trust deficit that comes with government-run programs. Governments set the objectives. PULZ builds the engagement. Citizens own the relationship.
The Upside
Potential National Impact if Deployed
If implemented at population scale, PULZ is designed to:
-
Reduce Medicaid and Medicare avoidable spend
-
Improve chronic disease outcomes across tens of millions
-
Enable real-time public health crisis detection
-
Strengthen national mental health monitoring
-
Improve health equity in measurable, data-driven ways
-
Expand the productive workforce
-
Slow the growth of federal and state health expenditures
This is not a technology product — It is a new infrastructure model designed for resilience, equity, and sustainable cost control.
Economic Impact Report
The PULZ Economic Impact Report provides a detailed and deliberately conservative assessment of how a precision-health economic operating system could reshape the U.S. healthcare landscape.
Across key stakeholder groups — including payers, employers, providers, wellness partners, pharmaceutical organizations, government programs, and individual patients — the analysis points to a consistent conclusion:
$260-B$510B
Estimated annual national value unlocked
Across payers, employers, providers, pharma, wellness partners, government programs, and patients under realistic adoption scenarios
$120B–$260B
Annual value opportunity for government programs
Driven by reduced preventable hospitalizations, chronic disease escalation, and unmanaged behavioral risk across Medicare, Medicaid, and public health systems
$180B–$300B
Annual economic impact for employers
From lower healthcare spend and recovered productivity tied to improved workforce health
$40B–$90B
Annual value for payers & health plans
Through reduced avoidable medical expenditure, improved adherence, and stabilized population risk
$30B–$55B
Annual value for providers
From improved care alignment, reduced downstream escalation, and better readiness in value-based environments
$10B–$21B
Annual value for pharma and research organizations
Through lower trial recruitment costs, faster enrollment, & higher-quality real-world evidence
$9B–$19B
Annual value for wellness and consumer health partners
From precision activation, higher conversion, and more efficient customer acquisition
$530B+
Annual productivity losses linked to chronic disease
Representing one of the largest hidden economic burdens on the U.S. economy
Statements regarding the potential to reduce Medicaid and Medicare avoidable spend, reflect preliminary economic modeling, scenario-based assumptions, and management estimates. Such projections are inherently uncertain and subject to numerous variables, including execution, user engagement, payer participation, regulatory compliance, interoperability, clinical outcomes, and market adoption. No assurance can be given that any projected economic benefit or cost reduction will be achieved in whole or in part.